Consequently, there is an increasing trend in clinical practice to combine TACE and MTAs to treat uHCC.
← all excerpts
Comparative efficacy and safety of molecular targeted agents combined with transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a network meta-analysis.
1
—
—